Le Lézard
Classified in: Health
Subjects: SVY, WOM

Fertility Test Market to Flourish at 7.2% CAGR to 2023 - Key Trends and Industry Insights


PUNE, India, July 20, 2018 /PRNewswire/ --

ReportsnReports.com adds the global fertility test market is projected to reach USD 583.1 million by 2023 from USD 411.8 million in 2018, at a CAGR of 7.2%. Growth in the fertility test market can be attributed to factors, such as increasing first-time pregnancy age, launch of advanced, easy-to-use fertility monitors with high accuracy, and increasing awareness about fertility testing.

Browse 71 Market Data Tables and 31 Figures spread through 140 Pages and In-depth TOC on "Fertility Test Market by Product (Ovulation Predictor Kits, Fertility Monitors (Urine & Saliva-based)), Mode of Purchase (OTC, Prescription), Application (Female, Male), End User (Home care, Fertility clinics, Hospital) - Global Forecast to 2023" at http://www.reportsnreports.com/reports/1571496-fertility-test-market-by-product-ovulation-predictor-kits-fertility-monitors-urine-saliva-based-mode-of-purchase-otc-prescription-application-female-male-end-user-home-care-fertility-clinics-hospi-st-to-2023.html .

SPD Swiss Precision Diagnostics (Switzerland), Church & Dwight (US), & Prestige Brands Holdings (US) held the leading position in fertility test market. These companies adopted product launches, enhancements, and acquisitions as their key growth strategies in the past three years. include Valley Electronics (Germany), Geratherm Medical (Germany), Hilin Life Products (US), Fairhaven Health (US), Fertility Focus (UK), bioZhena (US), TaiDoc Technology (Taiwan), UEBE Medical (Germany), AdvaCare Pharma (US), Ava (Switzerland), Babystart (UK), and Sensiia (UK) are some of the other major players operating in this market.

Stakeholders 

Geographically, fertility test market segmented into North America, Europe, Asia Pacific (APAC), & Rest of the World. The APAC market is expected to register highest growth rate during forecast period. Fast growth of this segment is mainly due to growing number of women suffering from lifestyle disorders, increasing healthcare expenditure in these regions, rising funding/investments for the development of fertility and ovulation monitors.

Order Now Research Copy of "Fertility Test Market by Product (Ovulation Predictor Kits, Fertility Monitors (Urine & Saliva-based)), Mode of Purchase (OTC, Prescription), Application (Female, Male), End User (Home care, Fertility clinics, Hospital) - Global Forecast to 2023" Report at http://www.reportsnreports.com/purchase.aspx?name=1571496 .

The fertility test market based on product, mode of purchase, application, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in the market and provides details of the competitive landscape for market leaders.

Additionally, factors such as the growing use of fertility monitoring devices for contraception, rising awareness about the benefits of ovulation monitors through social media, marketing campaigns, and e-commerce sites are increasing the adoption of fertility test in this region. The Asia Pacific region is expected to grow at the fastest CAGR as growing number of women suffering from lifestyle disorders, rising funding/investments for the development of fertility and ovulation monitors; and manufacturers and suppliers of fertility testing products are shifting their focus towards the Asian market.

Sample Brochure of Fertility Test Market Research Now at http://www.reportsnreports.com/contacts/requestsample.aspx?name=1571496 .

The report covers the fertility test market across four key geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America is expected to dominate the global market in 2018. The decline in fertility rate, rising first-time pregnancy age, and high prevalence of PCOS (polycystic ovary syndrome) among North American women are few of the major factors contributing the large share of this regional segment.

Fertility test market is divided into two segments prescription-based and non-prescription/OTC-based. In 2018, non-prescription/OTC-based segment is expected to account for a larger share of market. Large share can be attributed to factors such as increasing patient preference for home- and remote monitoring, e-commerce availability, confidentiality, & accessibility of test results, & growing initiatives taken by leading market players to develop easy-to-use and accurate products.

Key Insights
1 Fertility Test Market Overview
2 Regional Analysis: Market, By Product
3 Fertility Testing Monitors Market, By Product
4 Fertility Test Market, By Mode of Purchase
5 Fertility Test Market, By Application
6 Regional Analysis: Market, By End User
7 Market, By Country

Another research titled global infertility treatment market is expected to reach USD 2.05 billion by 2022 from USD 1.24 billion in 2017, at a CAGR of 10.6% from 2017 to 2022. Growth in this market is primarily driven by factors such as the continuous decline in fertility rates; increasing public-private investments, funds, and grants; growing public awareness about infertility and the available treatment options. Some of the prominent players are Cooper Companies Inc. (U.S.), Cook Group Incorporated (U.S.), and Thermo Fisher Scientific, Inc. (U.S.) and it is now available with discount at http://www.reportsnreports.com/contacts/discount.aspx?name=992560 .

Explore More Reports on Medical Devices Market Research Available Now at http://www.reportsnreports.com/market-research/medical-devices/

About Us: 

ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Contact:
Hrishikesh Patwardhan
2nd Floor, Metropole Building,
Next to Inox Theatre,
Bund Garden Road, Pune - 411001.
Maharashtra, India.
+1-888-391-5441
[email protected]  

Connect with Us: 
LinkedIn: http://www.linkedin.com/company/reportsnreports
RSS/Feeds: http: //http://www.reportsnreports.com/feed/l-latestreports.xml


SOURCE ReportsnReports


These press releases may also interest you

19 avr 2024
Remedium Healthcare Products is proud to announce the launch of NuVeria Labs' revolutionary Sacral Silicone Dressing, now available for purchase on Amazon, bringing advanced wound care solutions directly to consumers' doorsteps. Designed to address...

19 avr 2024
Getting specialty medications into...

19 avr 2024
Arthrex, a global leader in minimally invasive surgical technology, has once again taken home prestigious medals for product innovation at the 37th annual Edison Awards. "This product, along with our other innovations,...

19 avr 2024
Aligned with the trend of immersive water therapy in 2024, Baros Maldives' Serenity Spa stands out as an oasis of indulgent spa and beauty rituals, boasting a 50-year legacy of luxury. Nestled within a tranquil sanctuary amidst the lush Maldivian...

19 avr 2024
Oragenics, Inc. , a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it received a notice (the "Notice") from the NYSE American LLC (the "NYSE American") dated April...

19 avr 2024
Building on a successful phase one in which STChealth proved that the Universal Patient Identifier (UPI)?powered by Experian Health's Universal Identity Manager (UIM) and NCPDP Standardstm?can accurately identify patients across multiple datasets in...



News published on and distributed by: